Submission: “Life Sciences? How ‘Maximizing Shareholder Value’ Increases Drug Prices, Restricts Access, and Stifles Innovation.”
Lead Author: William Lazonick
Additional Author(s): Matt Hopkins, Ken Jacobson, Mustafa Erdem Sakinç, Öner Tulum
Click here to read the submission from The Academic-Industry Research Network (A)